Malignant pleural mesothelioma in Turkey, 2000-2002

Area of Science:

• Environmental health
• Oncology
• Pathology

Background:

• Malignant pleural mesothelioma (MPM) is a significant health concern in Turkey, associated with both asbestos and erionite exposure.
• Erionite is more potent than asbestos in causing lung cancer.
• Familial clustering suggests a potential genetic predisposition to mesothelioma.

Purpose of the Study:

• To investigate the etiological factors and prognostic indicators of malignant pleural mesothelioma in Turkey.
• To compare the clinical outcomes and pathogenic roles of asbestos versus erionite exposure.
• To evaluate the utility of proliferation index and staging systems in predicting patient outcomes.

Main Methods:

• Retrospective analysis of mesothelioma cases.
• Comparison of survival rates between asbestos- and erionite-induced MPM.
• Assessment of proliferation index as a prognostic marker.
• Evaluation of the new TNM staging system for MPM.

Main Results:

• Erionite exposure shows higher potency than asbestos.
• Patients with asbestos-induced MPM demonstrated a survival advantage compared to those with erionite-induced MPM.
• Neither Simian virus 40 (SV40) nor human herpes virus 8 (HHV-8) were identified as co-factors in environmentally induced mesothelioma.
• Proliferation index (PI) was identified as an independent prognostic factor.

Conclusions:

• Asbestos and erionite are key etiological agents for MPM in Turkey.
• Proliferation index and the TNM staging system are valuable prognostic tools for MPM patients.
• Further research integrating these factors may improve mesothelioma investigation and evaluation.